| Schedule of liabilities measured at fair value on the condensed consolidated balance sheet |
The following are the liabilities measured at fair value on the condensed consolidated balance sheet at September 30, 2022 and September 30, 2021 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 1:
Quoted Prices
in Active
Markets for Identical
Assets | | Level 2:
Significant
Other
Observable
Inputs | | Level 3:
Significant
Unobservable
Inputs | | Total at September 30,
2022 | | Total Gains (Losses) For The Three Months Ended September 30, 2022 | | Total Gains (Losses) For The Nine Months Ended September 30, 2022 | | | Recurring fair value measurements | | | | | | | | | | | | | | Warrants liability | $ | — | | | $ | — | | | $ | 12,000 | | | $ | 12,000 | | | $ | 170,000 | | | $ | 854,000 | | | | Derivative liability - non-controlling redeemable preferred shares | — | | | — | | | 531,257 | | | 531,257 | | | (40,245) | | | (19,309) | | | | Total recurring fair value measurements | $ | — | | | $ | — | | | $ | 543,257 | | | $ | 543,257 | | | $ | 129,755 | | | $ | 834,691 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 1:
Quoted Prices
in Active
Markets for Identical
Assets | | Level 2:
Significant
Other
Observable
Inputs | | Level 3:
Significant
Unobservable
Inputs | | Total at September 30,
2021 | | Total Gains (Losses) For The Three Months Ended September 30, 2021 | | Total Gains (Losses) For The Nine Months Ended September 30, 2021 | | Recurring fair value measurements | | | | | | | | | | | | | Private warrants | $ | — | | | $ | — | | | $ | 626,000 | | | $ | 626,000 | | | $ | 557,000 | | | $ | 627,228 | | | Derivative liability - non-controlling redeemable preferred shares | — | | | — | | | 509,785 | | | 509,785 | | | (12,179) | | | (12,179) | | | Total recurring fair value measurements | $ | — | | | $ | — | | | $ | 1,135,785 | | | $ | 1,135,785 | | | $ | 544,821 | | | $ | 615,049 | |
|
| Schedule of fair value on a recurring basis |
The following is a reconciliation of the opening and closing balances for the liabilities related to the private warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2022: | | | | | | | | | | | | | Warrants Liability | | Non-controlling redeemable preferred shares - derivative liability | | Balance at December 31, 2021 | $ | 866,000 | | | $ | 511,948 | | | | | | | Total (gains) losses for period included in earnings | (433,000) | | | (53,472) | | | Balance at March 31, 2022 | 433,000 | | | 458,476 | | | Total (gains) losses for period included in earnings | (251,000) | | | 32,536 | | | Balance at June 30, 2022 | 182,000 | | | 491,012 | | | | | | | Total (gains) losses for period included in earnings | (170,000) | | | 40,245 | | | Balance at September 30, 2022 | $ | 12,000 | | | $ | 531,257 | |
|